Looking back at lockdown
A new report published by IHPN examines how the sector has responded to the needs of the NHS during the first three months of...
NHS reform back on the agenda
IHPN CEO David Hare examines what the new White Paper
proposals mean for the independent healthcare sector
It’s been two years since NHS England first published...
A holistic approach to aesthetics
Lack of regulation and negative headlines have helped tarnish the reputation of aesthetic medicine in recent years, but it wasn’t always thus. Professor Steve...
Out of the shadows
Child and adolescent mental health services are in crisis with some figures suggesting just 12.5% of those children in need are in contact with...
Cosmetic treatments – a new generation
New research from LaingBuisson suggests that demand for cosmetic surgery has softened since the global economic crisis and PIP scandal but non-surgical treatments are...
Radiopharmaceuticals: hot or not?
The radiopharmaceuticals sector is attracting interest from private equity and corporates alike, but what does it take to succeed in a sector where barriers...
Resetting the consultant dynamic
In the third and final part of our three-part series exploring the impact of the Covid-19 pandemic on the private healthcare market, Check4Cancer chief...
Divided we rise?
As the UK hunkered down for its first Covid lockdown last April, Candesic’s Dr Joe Taylor raised the prospect that immunity passports could pave...
The doctor will see you now
The crisis in primary care has coincided with a ‘want it now’ consumer culture and the digital technology to make on-demand access a reality....
Have baby, will travel
Despite huge medical advances over recent years, national policy on funding and access to fertility treatment varies widely from country to country. As regulation...
©2023 All rights reserved LaingBuisson 
